Cytochrome P450c17α gene (CYP17) polymorphism predicts use of hormone replacement therapy

Cancer Research

Volumn 59, Issue 16, 1999, Pages 3908-3910

  Feigelson, Heather Spencer ^a   McKean Cowdin, Roberta ^a   Pike, Malcolm C ^a   Coetzee, Gerhard A ^a   Kolonel, Laurence N ^b   Nomura, Abraham M Y ^b   Marchand, Loic Le ^b   Henderson, Brian E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; STEROID 17ALPHA MONOOXYGENASE;

ADULT; AGED; ARTICLE; CANCER RISK; ESTROGEN METABOLISM; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; STEROIDOGENESIS; SUBSTITUTION THERAPY; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POSTMENOPAUSE; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0033566375     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 350: 1047-1059, 1997.
2. Brentano, S. T., Picado-Leonard, J., Mellon, S. H., Moore, C. C. D., and Miller, W. L. Tissue-specific cyclic adenosine 3′,5′-monophosphate-induced and phorbol esterrepressed transcription from the human P450c17 promoter in mouse cells. Mol. Endocrinol., 4: 1972-1979, 1990.
3. Carey, A. H., Waterworth, D., Patel, K., White, D., Little, J., Novelli, P., Franks, S., and Williamson, R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet., 3: 1873-1876, 1994.
4. Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z., and Henderson, B. E. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res., 58: 585-587, 1998.
5. Haiman, C. A., Hankinson, S. E., Spiegelman, D., Colditz, G. A., Willett, W. C., Speizer, F. E., Kelsey, K. T., and Hunter, D. J. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res., 59: 1015-1020, 1999.
6. Kolonel, L. N., Henderson, B. E., Hankin, J. H., Nomura, A. M. Y., Wilkens, L. R., Pike, M. C., Stram, D. O., Monroe, K. R., Earle, M. E., and Nagamine, F. S. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am. J. Epidemiol., in press, 1999.
7. Talmud, P., Tybjaerg-Hansen, A., Bhatnagar, D., Mbewa, A., Miller, J. P., Durrington, P., and Humphries, S. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis, 89: 137-141, 1991.
8. Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., and Henderson, B. E. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res., 57: 1063-1065, 1997.
9. Dunning, A. M., Healey, C. S., Pharoah, P. D. P., Foster, N. A., Lipscombe, J. M., Redman, K. L., Easton, D. F., Day, N. E., and Ponder, B. A. J. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br. J. Cancer, 77: 2045-2047, 1998.
10. Chern, H. D., Huang, C. S., Shen, C. Y., Yang, S. Y., Chang, K. J. Association of CYP17 with the susceptibility of breast cancer in Taiwan. Proc. Am. Assoc. Cancer Res., 39: 393, 1998.
11. Weston, A., Pan, C., Bleiweiss, I. J., Ksieski, H. B., Roy, N., Maloney, N., and Wolff, M. S. CYP17 genotype and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 7: 941-944, 1998.
12. Helzlsouer, K. J., Huang, H. Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Comstock, G. W., and Bell, D. A. Association between CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol. Biomark. Prev., 7: 945-949, 1998.